YC
Yuval Cohen (Chief Executive Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Corbus Pharmaceuticals Holdings, Inc. (CRBP). The largest single filing was $171K of CRBP (17,000 sh × $10.08, as filed), executed Aug 7. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$279K
shares × price, as filed
Last traded
Aug 7
Filed Aug 10
Median ADV $5.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $751K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
CRBPRecent filings
CRBPSALE
Corbus Pharmaceuticals Holdings, Inc.
View filing →
$171K17,000 sh × $10.08
Exec Aug 7
Filed Aug 10 · 4:30 PM ET CRBPSALE Corbus Pharmaceuticals Holdings, Inc. View filing → $108K
13,871 sh × $7.78
Exec Feb 13
Filed Feb 18 · 5:30 PM ET CRBPSALE Corbus Pharmaceuticals Holdings, Inc. View filing → $471K
27,633 sh across 2 lots
Exec Oct 24 2025
Filed Oct 27 2025 · 5:30 PM ET